Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Ischemia from Nonculprit Stenoses Is Not Associated with Reduced Culprit Infarct Size in Patients with ST-Segment-Elevation Myocardial Infarction

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Patient-Specific Computer Simulation of Transcatheter Aortic Valve Replacement in Bicuspid Aortic Valve Morphology

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Morphology and Function of the Lymphatic Vasculature in Patients With a Fontan Circulation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Left Atrial Function in Heart Failure With Reduced Ejection Fraction

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Background: In patients with ST-segment-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention, reperfusion injury accounts for a significant fraction of the final infarct size, which is directly related to patient prognosis. In animal studies, brief periods of ischemia in noninfarct-related (nonculprit) coronary arteries protect the culprit myocardium via remote ischemic preconditioning. Positive fractional flow reserve (FFR) documents functional significant coronary nonculprit stenosis, which may offer remote ischemic preconditioning of the culprit myocardium. The aim of the study was to investigate the association between functional significant, multivessel disease (MVD) and reduced culprit final infarct size or increased myocardial salvage (myocardial salvage index [MSI]) in a large contemporary cohort of STEMI patients. Methods: Cardiac magnetic resonance was performed in 610 patients with STEMI at day 1 and 3 months after primary percutaneous coronary intervention. Patients were stratified into 3 groups according to FFR measurements in nonculprit stenosis (if any): angiographic single vessel disease (SVD), FFR nonsignificant MVD (functional SVD), or FFR-significant, functional MVD. Results: A total of 431 (71%) patients had SVD, 35 (6%) had functional SVD, and 144 (23%) had functional MVD. There was no difference in final infarct size (mean infarct size [%left ventricular mass] SVD, 9±3%; functional SVD, 9±3%; and functional MVD, 9±3% [P=0.82]) or in MSI between groups (mean MSI [%left] SVD, 66±23%; functional SVD, 68±19%; and functional MVD, 69±19% [P=0.62]). In multivariable analyses, functional MVD was not associated with larger MSI (P=0.56) or smaller infarct size (P=0.55). Conclusions: Functional MVD in nonculprit myocardium was not associated with reduced culprit final infarct size or increased MSI following STEMI. This is important knowledge for future studies examining a cardioprotective treatment in patients with STEMI, as a possible confounding effect of FFR-significant, functional MVD can be discarded. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: NCT01435408 (DANAMI 3-iPOST and DANAMI 3-DEFER) and NCT01960933 (DANAMI 3-PRIMULTI).

Original languageEnglish
JournalCirculation: Cardiovascular Imaging
Volume14
Issue number5
Pages (from-to)416-425
Number of pages10
ISSN1941-9651
DOIs
Publication statusPublished - May 2021

    Research areas

  • acute coronary syndromes, cohort studies, magenetic resonance imaging, myocardium, reperfusion injury, Severity of Illness Index, Coronary Stenosis/complications, Prognosis, Ventricular Function, Left/physiology, Humans, Middle Aged, Male, Stroke Volume/physiology, Treatment Outcome, ST Elevation Myocardial Infarction/etiology, Coronary Angiography, Fractional Flow Reserve, Myocardial/physiology, Female, Coronary Vessels/diagnostic imaging, Percutaneous Coronary Intervention

ID: 67233851